Search Results 151-160 of 28519 for crohns disease
Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult ...
A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI) · Share ...
The purpose of this study is to evaluate the long-term safety of a single dose of darvadstrocel in participants with Crohn's disease (CD) and complex perianal ...
The purpose of this study is to evaluate safety and efficacy of ozanimod in subjects with moderately to severely active Crohn's Disease. Participation ...
2017. Uniting Cure and Care AwardCrohn's and Colitis Foundation of America · 2016. International Lifetime Achievement AwardPediatric Gastroenterology, ...
William Faubion Jr., a Mayo Clinic gastroenterologist, says inflammatory bowel disease is an umbrella term that covers Crohn's disease and ulcerative colitis, ...
... Crohn's disease. Autologous means that these cells that coat the plug come from you. You will be in this study for two years. There is potential to continue ...
... Crohn's Disease. It also aims to assess clinical and radiologic components of fistula remission, safety of treatment, disease activity, patient Quality of ...
... inflammatory bowel disease (IBD) (Crohn's ... Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.
... and inflammatory bowel disease. ... On the other hand, cigarette smoking appears to worsen Crohn's disease, another form of inflammatory bowel disease.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can go twice as far to fight cancer.